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Quantitative real-time PCR (qPCR) is broadly used to detect and quantify nucleic acid targets. In order to determine cell copy
number and genome equivalents, a suitable reference gene that is present in a defined number in the genome is needed, preferably
as a single copy gene. Formost organisms, a variable number of glyceraldehyde-3-phosphate dehydrogenase (GAPDH)pseudogenes
have been reported. However, it has been suggested that a single-copy of the GAPDH pseudogene is present in the feline genome
and that a GAPDH assay can therefore be used to quantify feline genomic DNA (gDNA). The aim of this study was to determine
whether one or more GAPDH pseudogenes are present in the feline genome and to provide a suitable alternative qPCR system for
the quantification of feline cell copy number and genome equivalents. Bioinformatics and sequencing results revealed that not just
one but several closely related GAPDH-like sequences were present in the cat genome. We thus identified, developed, optimized,
and validated an alternative reference gene assay using feline albumin (fALB). Our data emphasize the need for an alternative
reference gene, apart from the GAPDH pseudogene, for the normalization of gDNA levels. We recommend using the fALB qPCR
assay for future studies.
1. Introduction
Fluorescence-based quantitative real-time PCR (qPCR) is a
highly sensitive method for the detection and quantification
of nucleic acids. Due to its conceptual simplicity, sensitivity,
specificity, and speed, qPCR applications can be found in
a variety of fields, including medicine and the life sciences
[1, 2]. In clinical diagnostics, qPCR is broadly used for the
detection and quantification of bacterial and viral loads, gene
dosage determination, cancer diagnostics, and applications in
forensic medicine [3–7].
To assess the cell number present in a PCR reaction, the
coanalysis of suitable reference genes is crucial. Such refer-
ence genes should be single-copy number genes and should
not frequently undergo genetic alterations, to allow the
accurate normalization of genomic DNA (gDNA) samples.
In addition, internal control genes are also used to investigate
abnormalities in gene number, and amplified oncogenes have
been shown to have diagnostic, prognostic, and therapeutic
relevance. Thus, TaqMan PCR-based gene quantification
assays are also used to identify allelic imbalances (germ-line
deletions or amplifications), for example, in individuals suf-
fering from breast cancer, cutaneous melanoma, or nervous
system tumors [8, 9].
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
represents a universally expressed reference gene that has
many biological roles in addition to its function in glycol-
ysis. A GAPDH assay has been developed for the accurate
normalization of feline messenger RNA (mRNA) expression
[10], and this assay was recently validated and compared
to other potential feline mRNA reference gene assays [11].
Subsequently, the GAPDH assay was also applied as quality
control to test for the integrity of the gDNA and the absence
of PCR inhibitors [10, 12, 13]. One report suggested that a
single copy of the GAPDHpseudogene is present in the feline
genome and that the feline GAPDH assay can therefore be
used to quantify cell number in feline samples [14]. However,
no information on the exact position or the sequence of
this GAPDH pseudogene was provided [14]. In contrast, a
variable number of GAPDH pseudogenes has been reported
for other organisms [15, 16].
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Pseudogenes for many different genes have been found
in all animal genomes studied so far [17]. Due to the high
sequence similarity of the pseudogenes to their “parent”
gene, pseudogenes often interfere with PCR or hybridization
experiments that are intended to detect the genes only [18, 19].
Specifically, processed pseudogenes typically lack introns and
are therefore well known to hamper data interpretation in
mRNA transcription analysis [18, 20]. Promising clinical
applications of RT-PCR assays for the purpose of early
diagnosis and relapse monitoring of micrometastatic tumor
cells have suffered from false-positive results due to their
interferencewith corresponding pseudogenes in the past [19].
Thus, the aim of this study was to (i) investigate the number
and sequence(s) of the GAPDH pseudogene(s) in the feline
genome, with a specific focus on the GAPDH assay region
that is frequently used to normalize genome equivalents
[14] and (ii) provide a suitable alternative qPCR system for
the normalization of the amount of input gDNA and the
determination of cell number in feline samples.
2. Materials and Methods
2.1. Sample Description. All cats included in this study were
in experimental studies officially approved by the Veterinary
Office of the Swiss Canton of Zurich (TVB 30/2003, 59/2005,
and 99/2007). The cats were kept in groups under optimal
ethological conditions in a barrier facility, as previously
described [21]. All cats were euthanized for reasons unrelated
to the present study.
Tissue samples were collected upon necropsy from two
feline leukemia virus-infected cats (cat B8, female 3.8 years
old, and cat 15, neutered male, 1.3 years old). The cats under-
went histopathological examination, and samples from the
rectum, colon, spleen, and jejunum were collected. Tissues
for histology were processed as described [22], histologically
examined, and verified to be free of pathological abnormali-
ties. The samples for molecular analysis were snap frozen in
liquid nitrogen following collection and stored at −80∘C until
nucleic acid extraction.
2.2. Nucleic Acid Extractions. Tissues (approximately 25mg)
were homogenized prior to extraction in 180 𝜇L ATL buffer
(Qiagen, Hombrechtikon, Switzerland) for genomic DNA
isolation. The samples were processed using the DNeasy
Blood & Tissue Kit (Qiagen) following the manufacturer’s
recommendations. For all nucleic acid extractions, negative
controls consisting of 100 𝜇L of phosphate-buffered saline
were prepared with each batch to monitor cross-contamina-
tion.
2.3. GAPDH Pseudogene Sequencing. For the analysis of the
GAPDH-like sequences of the domestic cat, gDNA was
obtained from tissue samples from two cats (cat B8, rectum
and colon, and cat 15, spleen and jejunum).
Primers were designed using Primer Express software
(Version 3, Applied Biosystems, Rotkreuz, Switzerland) based
on the GAPDH mRNA sequence [23] to encompass the
previously published TaqMan sequence [10]. PCR amplifica-
tion of the GAPDH pseudogenes using the forward primer
binding the exon 2 (GCGCCTGGTCACCAGGGCTGC; pb
position: 39–59) and the reverse primer located on the
exon 4 (GACTCCACAACATACTCAGCACCAGCATCAC;
bp position: 287–257) resulted in an approximately 249 bp
fragment. To ensure a high fidelity of amplification, the
PCR was performed using Phusion polymerase and HF
buffer (Finnzymes, Ipswich, UK), 500 nM of each primer,
and 2 𝜇L of extracted gDNA in a final volume of 20𝜇L.
The cycling conditions were as follows: initial denaturation
for 2min at 98∘C, followed by 40 cycles of 20 sec at 98∘C,
30 sec at 70∘C, and 20 sec at 72∘C prior to a final elongation
at 72∘C for 10min. The PCR products were separated by
2.5% agarose gel electrophoresis, excised from the gel, puri-
fied using the GenElute Gel Extraction Kit (Sigma-Aldrich,
Buchs, Switzerland), and cloned into the pCRII-TOPO TA
cloning vector (Invitrogen, Basel, Switzerland) according to
the manufacturer’s instructions. A total of 15 of the obtained
cloneswere sequenced byMicrosynth (Balgach, Switzerland).
The sequences were analyzed using Clone Manager
Professional software version 7.01 (Scientific & Educational
Software, Cary, NC, USA).
2.4. Alternative qPCR Assay Design. In other species, albu-
min (ALB) is known to be a single-copy gene and therefore
it has been used as an internal control gene [8, 9, 24, 25]. In
order to determine whether feline ALB (fALB) is also present
as a single-copy gene, sequence and gene organization infor-
mation of the feline genome were retrieved from GenBank
(no. NM 001009961) and Ensembl (ENSFCAG00000011854).
Subsequently, a fALB qPCR assay was designed.The TaqMan
hydrolysis probe and primers for the fALB assay were
designed using Primer Express software (Version 2, Applied
Biosystems; Table 1). The primer pair (Microsynth, Table 1)
was tested to ensure that it amplified a product of the
appropriate length using 5 𝜇L gDNA in a total volume
of 25 𝜇L per reaction with an ABI Prism 7700 sequence
detection system (Applied Biosystems) and the TaqMan Fast
Universal PCR Master Mix (Applied Biosystems). The PCR
products were analyzed by gel electrophoresis in a 3% agarose
gel stained with ethidium bromide, and the bands were
visualized using the ChemiGenius 2 Bio Imaging System
(Syngene, Cambridge, UK).
The qPCR reactions were performed as described [11]
from gDNA extracted from tissues (diluted 1 : 10). The ther-
mocycling conditions consisted of initial denaturation at
95∘C for 20 sec followed by 45 cycles of 95∘C for 3 sec and
60∘C for 45 sec. The gDNA was amplified and quantified
using a Rotor-Gene 6000 real-time rotary analyzer (Corbett,
Mortlake, VIC, Australia) and an ABI Prism 7700 sequence
detection system (Applied Biosystems).
2.5. Production of a Standard for Absolute fALB Quantifi-
cation. Cat gDNA was used to generate an fALB standard
template for absolute quantification. A 150 bp sequence,
consisting of the fALB TaqMan sequence, was amplified from
2 𝜇L target gDNA using the fALB primers (Table 1). The PCR
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Table 1: Details of the TaqMan real-time PCR assays.
Gene Oligo Sequence (5󸀠 → 3󸀠) Amplicon size (bp) Final conc. (nM)
GAPDH1
Forward GCCATCAATGACCCCTTCAT
82
480
Reverse GCCGTGGAATTTGCCGT 480
Probe CTCAACTACATGGTCTACATGTTCCAGTATGATTCCA2 160
ALB3
Forward GATGGCTGATTGCTGTGAGA
150
500
Reverse CCCAGGAACCTCTGTTCATT 500
Probe ATCCCGGCTTCGGTCAGCTG2,4 200
1[10]; 25󸀠FAM/3󸀠TAMRA; 3present study; 4HPLC purification.
reaction contained 2.5 units Taq DNA polymerase (Sigma),
final concentrations of 250 nM of each primer, 200𝜇M
dNTPs (Sigma), 2𝜇L 10 × PCR buffer (Sigma), and 2𝜇L of
template in a final volume of 20𝜇L. The amplification was
performed using a Biometra TPersonal thermal cycler (Bio-
labo, Chaˆtel-St-Denis, Switzerland). The cycling conditions
consisted of an initial denaturation at 94∘C for 2min followed
by 40 cycles of 94∘C for 30 sec, 55∘C for 30 sec, and 72∘C for
15 sec, with a final extension at 72∘C for 2min. The resulting
amplicon was gel-purified and cloned into the TOPO TA
cloning vector (Invitrogen). The inserts in selected clones
were verified by sequencing using an ABI PRISM 310 genetic
analyzer (Applied Biosystems), as described [26]. The fALB
reference plasmid was linearized by restriction digestion
using the enzyme SalI (Roche, Rotkreuz, Switzerland) and
gel-purified (Gen Elute PCR Clean-Up Kit, Sigma-Aldrich),
and the copy number was determined spectrophotometri-
cally (GeneQuant, Pharmacia Biotech) and by agarose gel
electrophoresis (ChemiGenius 2 Bio Imaging System). Ten-
fold serial dilutions of the standard templates in 30𝜇g/mL
carrier salmon sperm DNA (Invitrogen) were aliquoted and
frozen at −20∘C, as described [27].
2.6. Efficiency, Analytical Sensitivity, Linear Range, and Pre-
cision of the fALB qPCR Assay. The newly designed fALB
qPCR assay was evaluated according to the MIQE guidelines
[28] using the Rotor-Gene 6000 real-time rotary analyzer
(Corbett). The efficiency of the assay was calculated as
previously described [29], using the following equation: 𝐸 =
(10
(−1/slope)
) − 1. The analytical sensitivity of the system was
defined by an endpoint dilution experiment using the ten-
fold serially diluted standard template and ten replicates per
dilution, as described [27]. The linear range of amplification
of the fALB qPCR assay was determined by ten-fold serial
dilution of the linearized standard template. For the precision
analysis, a dilution of a standard template containing 105
copies of fALB per reaction was chosen and assayed 10 and
13 times for the intrarun and interrun precision, respectively,
and the mean value, standard deviation, and coefficients of
variation were calculated.
2.7. Nucleotide Sequence Accession Numbers. The sequence
of the partial GAPDH pseudogene of the cat B8 sample
(clone 14) was submitted to GenBank under accession num-
ber JX523658.
3. Results
3.1. Investigation of the GAPDH Pseudogene Sequence. An
approach combining sequencing and bioinformatics was
chosen to investigate the presence of potential GAPDH
pseudogenes in the domestic cat genome. The potential
target sequence of the GAPDH qPCR assay was amplified
and cloned, and 15 clones were sequenced: 10 from cat
B8 and 5 from cat 15. The sequencing of these 15 clones
yielded 11 distinct sequences similar to that of the feline
GAPDH mRNA (GenBank: NM 001009307). Eight different
sequences were found within the target region of the primers
and/or the hydrolysis probe of the GAPDH TaqMan assay
(Figure 1). Overall, the sequence identity ranged from 82%
(cat 15, clone 20: cat 15 20, Figure 1) to 96% (cat B8, clone 9:
cat B8 9) in comparison to the reference sequence (GenBank:
NM 001009307).
Sequence and gene organization information were
retrieved from the Genome Annotation Resource Fields Felis
catus v12.2 website (GARFIELD) http://lgd.abcc.ncifcrf.gov/
[30], and five sequences termed “similar to GAPDH” were
found in the feline genome. One of these sequences on
chromosome F2 exhibited 100% similarity to clone 14 of
cat B8 (cat B8 14, Figure 1). In addition, the GAPDH assay
sequence was searched using BLAST against the “AANG
WGS Contigs” database containing the Felis catus whole-
genome shotgun sequencing project (Felis catus-6.2; 14×
coverage; [GenBank: AANG02000000]). Over 60 different
contigs containing sequence similar to the GAPDH assay
sequence were detected. The sequence with the best fit had
three mismatches with the sequence of the GAPDH assay:
two mismatches with the forward primer and one mismatch
with the reverse primer.
3.2. Efficiency, Analytical Sensitivity, Linear Range, and Preci-
sion of the fALB qPCRAssay. In order to confirm the absence
of pseudogenes for feline ALB, a bioinformatics approach
was chosen. Sequence and gene organization informationwas
retrieved from the GARFIELD website [30] and the second
draft assembly, Felis catus-6.2 (GenBank: AANG02000000).
Only one sequence termed “albumin” indicative of the albu-
min gene, was detected; it is located on chromosome B1.
Subsequently, a fALB real-time PCR assay was designed
to amplify a sequence located within the exon IV of the feline
albumin. The amplification of feline gDNA using the newly
designed primers yielded PCR products with the expected
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Figure 1: Comparison of feline GAPDH and pseudo-GAPDH nucleotide sequences. A comparison of the nucleotide sequences of feline
GAPDH mRNA (GenBank: NM 001009307, position 60 to 256, and GenBank: AF097177, position 63 to 228) and gDNA sequences similar
to GAPDH retrieved from cat B8 and cat 15.The number listed after the animal identifier (B8 and 15) represents the clone identity. Sequences
found in multiple clones are shown only once. Nucleotides that differ from those in the two reference strains are indicated. Primer sequences
for the qPCR reported previously [10] were located at positions 29 to 48 and 109 to 93, and the hydrolysis probe spans positions 53 to 89, as
indicated. Arrows point to the splicing sites and the intron sequence from the gDNA (Ensembl: ENSFCAG00000006874) is depicted (Intron
in gDNA).The exon sequences of the GAPDH gDNA (Ensembl: ENSFCAG00000006874) on which the GAPDH assay is located (exon 2 and
3) are 100% identical to the GAPDHmRNA sequence depicted in this figure (GenBank: NM 001009307).
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size of 150 bp, as determined by agarose gel electrophoresis.
The primers were then used in combination with the newly
designed probe, and the amplification efficiency of the fALB
qPCRwas determined to be 99.5% to 100%using 10-fold serial
dilutions of the standard template (Supplementary Material
available online at http://dx.doi.org/10.1155/2013/587680 and
data not shown). The highest dilution that still resulted in
a positive signal in the qPCR assay contained an average of
1 copy of the standard in a 5𝜇L reaction; in an endpoint
dilution experiment, 6 of the 10 replicates of this dilutionwere
positive.The fALB qPCR assay was linear over eight orders of
magnitude, from 101 to 108 copies (Supplementary Material).
The qPCR assay displayed a good precision; the coefficient of
variation for the absolute number using 105 copies/reaction
was 5.51% for the intrarun precision analysis and 6.39% for
the interrun analysis.
4. Discussion
In this report, we describe the detection of several GAPDH-
like sequences that are characteristic for processed GAPDH
pseudogenes in the domestic cat genome. Based on the
assumption that there is only one copy of the GAPDH
pseudogene in the domestic cat genome [14], the GAPDH
qPCR assay that was previously designed to amplify GAPDH
mRNA/complementary DNA (cDNA) [10] was regularly
used to determine the cell number of input gDNA. However,
in our experience, the analysis of gDNA samples resulted in
a lower amplification efficiency compared to cDNA (unpub-
lished observations); we hypothesized that this might occur
due to mismatches between the primers and/or hydrolysis
probe and the gDNA sample.Thus, we performed a sequence
analysis of the binding region of the primers and the hydroly-
sis probe of the GAPDH assay.The sequencing of 15 different
clones comprising the GAPDH assay sequence revealed 11
different GAPDH-like sequences; however, none exhibited
100% similarity to the GAPDH mRNA sequence (GenBank:
NM 001009307). It is possible that there are additional
GAPDH pseudogenes present in the feline genome that were
not detected in the present study because the sequencing was
restricted to 15 clones. The use of an alternative sequencing
technique (deep-sequencing rather than cloning followed by
Sanger dideoxy sequencing) may provide a broader picture
of the GAPDH-like sequences present in the cat genome.
Furthermore, the primer binding sites chosen within the
GAPDH sequence may have additionally restricted the num-
ber of recognized GAPDH pseudogenes. Thus, the number
of GAPDH pseudogenes or GAPDH-like sequences in the
feline genome may have been underestimated in our study.
However, our sequencing results readily demonstrate that
more than one feline GAPDH pseudogene is present in the
genomic DNA of feline cells, and the GAPDH pseudogene
sequences differed from the GAPDH mRNA sequence to
some extent.
This finding was supported by the sequence information
retrieved from the GARFIELD website [30] and the second
draft assembly, Felis catus-6.2 (GenBank: AANG02000000),
in which no sequence with 100% similarity to the GAPDH
mRNA sequence was found, but a multitude of closely
related sequences were present. Moreover, our data are in
agreement with studies investigating GAPDH pseudogenes
in other species. In humans, between 56 and 62 GAPDH
pseudogenes have been detected [15, 17]. Of note, the copy
number of pseudogenes may vary within a population, as has
been documented for the ATP-binding cassette transporter
pseudogene within the Chinese population [31]. The number
of recognized processed GAPDH pseudogenes may be as
high as 120 in dogs and is over 300 in murine rodents [15–17].
For glycolytic genes, including GAPDH, it has been shown
that there is a positive correlation between the level of gene
expression and the abundance of processed pseudogenes in
mice; GAPDH was found to be particularly highly expressed
and to generate the highest number of pseudogenes among
all glycolytic genes [17]. The authors explained the over-
abundance of GAPDH by the fact that GAPDH has many
additional functions other than those related to glycolysis
[17].
An alternative assay for the quantification of gDNA and
cell number in feline samples was designed, validated, and
implemented. In other species, different genes have been
used for the quantification of cells, including the chemokine
receptor CCR5 [32] and ALB [9]. ALB is known to be a
single-copy gene in other species, such as humans and rhesus
macaques, and has been used in both species as an internal
control gene [8, 9, 24, 25]. According to the GARFIELD
website [30], ALB is also present as a single-copy gene in
the feline genome. ALB has been used for the normalization
of retroviral provirus loads [24, 25, 33, 34]. We chose to
develop a feline albumin assay because one of our group’s
main scientific interests is in retroviral infections. The newly
implemented fALB assay was shown to be highly sensitive
and efficient for gDNA, with a wide range of linearity. Our
database searches resulted in only one hit termed “ALB.”Thus,
to the best of our knowledge, fALB is a single-copy number
gene.
5. Conclusions
This study investigated the number of GAPDH pseudogenes
in the domestic cat. Our results indicate that several closely
related GAPDH-like sequences are indeed present in the cat
genome. The GAPDH assay may still be used for quality
control to test for the integrity of gDNA and the absence of
PCR inhibitors. However, it appears to be a suboptimal choice
for the quantification of gDNA equivalents. A newly designed
assay using the fALB reference gene for the normalization of
gDNAwas validated and implemented.We recommendusing
this highly sensitive fALB qPCR assay for the normalization
of input genomic DNA equivalents in future studies.
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